Review Article | Volume: 8, Issue: 10, October, 2018

Role of Microbial Flora and Probiotics in Host Immune Homeostasis

Pratibha Mishra Sunil Kumar Mishra   

Open Access   

Published:  Oct 31, 2018

DOI: 10.7324/JAPS.2018.81018

Microbiota refers to an abundant and diverse population of bacteria, archaea, fungi and other microbial eukaryotic species reside in the gastrointestinal tracts and other body sites exposed to the environment. A Microbial symbiosis was established between the host and the microbial flora. The host provides a favorable environment for the colonization of microbiota and in respect to this microbial flora actively participates in the metabolic process of the host, synthesis of vitamins, production of nutrients, enhancement of mucosal barrier functions, and also inhibits the colonization of pathogens. In addition to this Microbial flora have the fundamental role in the development and establishment of host immune homeostasis. Microbiota induces the protective responses against the pathogens and modulates the regulatory pathways in such way to develop the tolerance against the innocuous antigens. Alteration in the composition of microbial flora results in many gastrointestinal diseases including obesity, inflammatory bowel diseases, systemic infections, autoimmune disorders, and even colon cancers. These features of microbiota focus the research on their composition and a wide range of their functional aspects. The objective of this review is to explore the symbiotic relationship between intestinal microbiota and host, the contribution of the microbial flora in host immune homeostasis as well as the concept of ‘probiotics’ as a possible therapeutic approach to restore the normal gut microbial flora and host immune homeostasis.

Keyword:     MicrobiotaMicrobial symbiosisImmunomodulatoryAutoimmune disordersImmune homeostasisProbiotics.


Mishra P, Mishra SK. Role of Microbial Flora and Probiotics in Host Immune Homeostasis. J App Pharm Sci, 2018; 8(10): 136-149.

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Alakomi HL, Skytta E, Saarela M, Mattila-Sandholm T, Latva- Kala K, Helander IM. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol, 2000; 66:2001-2005.

Vieira AT, Teixeira MM, Martins FS. The role of probiotics and prebiotics in inducing gut Immunity. Frontiers in immunology-Mucosal Immunity, 2013; 4(445):1-12.

Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, Deroos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 2013; 19, 504(7480):451-5.

Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, Narushima S, Suda W, Imaoka A, Setoyama H, Nagamori T, Ishikawa E, Shima T, Hara T, Kado S, Jinnohara T, Ohno H, Kondo T, Toyooka K, Watanabe E, Yokoyama S, Tokoro S, Mori H, Noguchi Y, Morita H, Ivanov II, Sugiyama T, Nunez G, Camp JG, Hattori M, Umesaki Y, Honda K. Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. Cell. 2015; 163(2):367-80.

Baddini Feitoza A, Fernandes Pereira A, Ferreira da Costa N, Gonçalves Ribeiro B. Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile. Nutr Hosp, 2009; 24(4):422-8.

Bhattacharjee A. Oral micro-particulate colon targeted drug delivery system for the treatment of Crohn's disease: A review. Int J Life Sci Pharm Res, 2012; 1:31-39.

Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The intelligent intestine," held in Paris, June 14, 2002. Am J Clin Nutr, 2003; 78:675-83.

Bourriaud C, Akoka S, Goupry S, Robins R, Cherbut C, Michel C. Butyrate production from lactate by human colonic microflora. Reprod Nutr Dev, 2002; 42:S55.

Bouskra D, Brezillon C, Berard M, Werts C, Varona R, Boneca IG, Eberl G. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature, 2008; 456:507-10.

Carvalho FA, Aitken JD, Vijay Kumar M, Gewirtz AT. Toll-like receptor-gut microbiota interactions: perturb at your own risk. Annu Rev Physiol, 2012; 74:177-98.

Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science, 2006; 313:1126-1130

Ohland CL, Jobin C. Microbial Activities and Intestinal Homeostasis: A Delicate Balance Between Health and Disease. Cellular and Molecular Gastroenterology and Hepatology, 2015; (1):28-39.

Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, Umesaki Y, Mathis D, Benoist C, Relman DA, Kasper DL. Gut immune maturation depends on colonization with a host-specific microbiota. Cell, 2012; 149:1578-93.

Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK. Pharmacometabonomic identification of a significant host microbiometabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA, 2009; 106:14728-14733.

Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cellsvia a TGF-beta and retinoic acid-dependent mechanism. J Exp Med, 2007; 204:1757-64.

Devillard E, McIntosh FM, Duncan SH, Wallace RJ. Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J Bacteriol, 2007; 189:2566-2570.

Devillard E, McIntosh FM, Paillard D, Thomas NA, Shingfield KJ, Wallace RJ. Differences between human subjects in the composition of the faecal bacterial community and faecal metabolism of linoleic acid. Microbiology, 2009; 155:513-520.

Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta bearing regulatory cells. J Immunol, 2005; 174:3237-46.

Gevers D, Palaniappan K, Weinstock G. 2012. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. In: Nature, 486, Macmillan Publishers Limited 207-214. Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr, 2000; 130(Suppl 2):S403-9.

Elliott PJ, Zollner TM, Boehncke WH. Proteasome inhibition: a new anti-inflammatory strategy. J Mol Med, 2003; 81:235-245.

Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S, Probiotics: effects on immunity, Am J Clin Nutr, 2001; 73(suppl):444S-50S.

Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K. Adaptive immune regulation in the gut: T cell dependent and T cell-independent IgA synthesis. Annu Rev Immunol, 2010; 28:243-73.

Franchi L, Kamada N, Nakamura Y, Burberry A, Kuffa P, Suzuki S, Shaw MH, Kim YG, Nunez G. NLRC4-driven production of IL-1beta discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat Immunol, 2012; 13:449-56.

Freestone PP, Walton NJ, Haigh RD, Lyte M. Influence of dietary catechols on the growth of enteropathogenic bacteria. Int J Food Microbiol, 2007; 119:159-169.

Fujimori S, Tatsuguchi A, Gudis K, et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J Gastroenterol Hepatol, 2007; 22(8):1199-204.

Karimi G, Sabran MR, Jamaluddin R, Parvaneh K, Mohtarrudin N, Ahmad Z. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats. Food Nutr Res, 2015; 59:1-9.

Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity, 2009; 31:677-89.

Gordon HA, Bruckner-Kardoss E, Wostmann BS. Aging in germ-free mice: life tables and lesions observed at natural death. J Gerontol, 1966; 21:380-7.

Guarner F, Malagelada JR, Gut flora in health and disease. Lancet, 2003; 361:512-9.

Hasegawa M, Osaka T, Tawaratsumida K, Yamazaki T, Tada H, Chen GY, Tsuneda S, Nunez G, Inohara N. Transitions in oral and intestinal microflora composition and innate immune receptor dependent stimulation during mouse development. Infect Immun, 2010; 78:639-50.

Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol, 2014; 11(8):506-514.

Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol, 2003; 4:269-273.

Hooper LV. Do symbiotic bacteria subvert host immunity? Nat Rev Microbiol, 2009; 7:367-374

Hui YH. 2006. Handbook of food science, technology, and engineering. In: Hi YH, ed. Taylor and Francis. CRC Press, volume 4.

Ivanov, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell, 2009; 139:485-98.

Joossens M, Huys G, Cnockaert M, de Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut, 2011; 60, 631-637.

Rodríguez JM, Murphy K, Carmen M. The composition of the gut microbiota throughout life, with an emphasis on early life. Microbial Ecology in Health & Disease, 2015; 26:26050

Kamada N, Hisamatsu T, Okamoto S, Sato T, Matsuoka K, Arai K, Nakai T, Hasegawa A, Inoue N, Watanabe N, Akagawa KS, Hibi T. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL- 23 in response to bacteria. J Immunol, 2005; 175:6900-8.

Kamada N, Nunez G. Role of the gut microbiota in the development and function of lymphoid cells. J Immunol, 2013; 190:1389- 95.

Todar K. The Normal Bacterial Flora of Humans. Web Review of Todar's (online) Textbook of Bacteriology, The Good, the Bad, and the Deadly, page 4, (Accessed, 2012).

Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep, 2010; 12:319-330.

Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: currentstatus and the future ahead. Gastroenterology, 2014; 146:1489-1499.

Kwon HK, Lee CG, So JS, et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci USA, 2010; 107:2159- 2164.

Leah G, Gillingham MS, Lescheid DW. Probiotics and Mucosal Immunity: Strain-specific effects on Th1/Th2 cell modulation. Int J N M, 2009; 4(1):18-22

López-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, Parks WC. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol, 2000; 148:1305-1315.

Lyte M, Vulchanova L, Brown DR. Stress at the intestinal surface: catecholamines and mucosa bacteria interactions. Cell Tissue Res, 2011; 343:23-32.

Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc, 2003; 62:67-72.

Macpherson AJ, Slack E. The functional interactions of commensal bacteria with intestinal secretory IgA. Curr Opin Gastroenterol, 2007; 23:673-678.

Magwira CA, Kullin B, Lewandowski S, Rodgers A, Reid SJ, Abratt VR. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group. J Appl Microbiol, 2012; 113:418-428.

Malchow HA. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease. J Clin Gastroenterol, 1997 Dec; 25(4):653-8.

Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol, 2012; 9:599-608.

Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 2005; 122:107-18.

Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature, 2008; 453:620-5.

Wilson M. 2004. Microbial Inhabitants of Humans: Their Ecology and Role in Health and Disease. Cambridge University Press; ISBN-10:0521841585.

Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol, 2016 May 27; 16(6):341-352.

Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol, 2012; 13:R79.

Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med, 2002; 8:567-73.

Otles S. 2013. Probiotics and prebiotics in food, nutrition and health. CRC Press.

Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell, 2004; 118:229-41.

Martín R, Miquel S, Ulmer J, Kechaou N, Langella P, Bermúdez- Humarán LG. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microbial Cell Factories, 2013; 12:71.

Rivollier A, He J, Kole A, Valatas V, Kelsall BL. Inflammation switches the differentiation program of Ly6Chi monocytes from anti-inflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med, 2012; 209:139-55.

Rooks MG, Veiga P, Wardwell-Scott LH, Tickle T, Segata N, Michaud M, Gallini CA, Beal C, Van Hylckama-Vlieg JE, Ballal SA, et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J, 2014; 8:1403- 1417.

Rossi M, Amaretti A, Raimondi S. Folate production by probiotic bacteria. Nutrients, 2011; 3:118-34.

Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science, 2011; 332:974-7.

Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA, 2010; 107:12204-9.

Rul F, Ben-Yahia L, Chegdani F, Wrzosek L, Thomas S, Noordine ML, Gitton C, Cherbuy C, Langella P, Thomas M. Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of genotobiotic rats. J Biol Chem, 2011; 286(12):10288-96.

Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN. Role of the normal gut microbiota. World J Gastroenterol, 2015; 21(29):8787-8803.

Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol, 2007; 19:70-83.

Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP. Microbial flora drives interleukin 22 productions in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity, 2008; 29:958-70.

Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut, 2003; 52:237- 242.

Shanahan F. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol, 2002; 16(6):915-931.

Shaw MH, Kamada N, Kim YG, Nunez G. Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med, 2012; 209:251-8.

Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet, 1998; 352:1026-1029.

Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity, 2014; 40:128-139.

Smith K, McCoy KD, Macpherson AJ. Use of axenic animal in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol, 2007; 19:59-69.

Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science, 2013; 341:569-73.

Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity, 2012; 37:601-10.

Sujatha S, Narayan, Jalgaonkar S, Shahani S, Kulkarni VN. Probiotics: current trends in the treatment of diarrhea. Hong Kong Med J, 2010; 16:213-8.

Mishra SK, Mishra P, Saxena M, Probiotics: An Approach for Better Treatment. RJPBCS, 2012; 3(2):1042-1061.

Suzuki K, Maruya M, Kawamoto S, Sitnik K, Kitamura H, Agace WW, Fagarasan S. The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut. Immunity, 2010; 33:71-83.

Takeuchi O, Akira S. Pattern recognition receptors and inflammation, Cell. 2010; 140:805-820.

Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature, 2016; 535(7610):65-74.

Tighe MP, Cummings J, Afzal NA. Nutrition and inflammatory bowel disease: Primary oradjuvant therapy. Curr Opin Clin Nutr Metab Care, 2011; 14:491-496.

Umesaki Y, Setoyama H, Matsumoto S, Imaoka A, Itoh K. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun, 1999; 67:3504-11.

Vasiljevic T, Shah NP. Probiotics—From Metchnikoff to Bioactives. International Dairy Journal, 2008; 18:714-28

Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, Redinbo MR. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science, 2010; 330:831-835.

Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, Russell JM, Bevins CL, Adams LG, Tsolis RM, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature, 2010; 467:426-429.

Belkaid Y, Hand TW. Role of the Microbiota in Immunity and Inflammation. Cell, 2014; 157(1):121-141

Zhang Y-J, Li S, Gan R-Y, Zhou T, Xu D-P, Li H-B. Impacts of Gut Bacteria on Human Health and Diseases. Int J Mol Sci, 2015; 16:7493- 7519.

Zarate G. Dairy Propionibacteria: Less conventional probiotics to improve the human and animal health. In: Probiotic in Animals. Intech, 2012. Chapter 8:153-202

Zhou L, Ivanov, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol, 2007; 8:967-74.

De La Cochetière MF, et al. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb. Ecol, 2008; 56:395-402.

Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature, 2008; 455:804- 807.

Wang Q, Yang S, Liu J, Terecskei K, Abraham E, Gombar A. Host-secreted antimicrobial peptide enforces symbiotic selectivity in Medicago truncatula. Proc Natl Acad Sci, 2017; 114:6854-6859.

Chu CM, Yao CT, Chang YT, Chou HL, Chou YC, Chen KH, Terng HJ, Huang CS, Lee CC, Su SL, Liu YC, Lin FG, Wetter T, Chang CW. Gene expression profiling of colorectal tumors and normal mucosa by microarrays meta-analysis using prediction analysis of microarray, artificial neural network, classification, and regression trees. Disease Markers, 2014; 634123:1-11.

Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Berard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Dore J, Kroemer G, Lepage P, Boneca IG, Ghiringhelli F, Zitvogel L. The intestinal microbial modulates the anticancer immune effects of cylcophosphamide. Science, 2013; 342:971-976.

Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, Jobin C, Lund PK. High-fat diet: bacteria interactions promote intestinal inflammation which precedes andcorrelates with obesity and insulin resistance in mouse. PLoS One, 2010; 5(8):1-13.

Hilderbrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology, 2009; 137:1716-24.

Safavi M, Farajian S, Kelishadi R, Mirlohi M, Hashemipour M. The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: A randomized triple-masked controlled trial. Int J Food Sci Nutr, 2013; 64:687-693.

Johnston BC, Ma SSY, Goldenberg JZ, Thorlund k, Vandvik PO, Loeb M, Guyatt GH. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med, 2012; 157(12):878-888.

Willing BP, Russel SL, Finlay BB. Shifting the balance: antibiotic effects on host–microbiota mutualism. Nature Reviews Microbiology, 2011; 9:233-243.

Morgen CS, Sorensen TI. Obesity: global trends in the prevalence of overweight and obesity. Nat Rev Endocrinol, 2014; 10:513-514.

Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment. Pharmacol, Ther. 2012; 35:1355- 1369.

Gorissen L, Raes K, Weckx S, Dannenberger D, Leroy F, De Vuyst L, De Smet S. Production of conjugated linoleic acid and conjugated linolenic acid isomers by Bifidobacterium species Appl Microbiol Biotechnol. Appl Microbiol Biotechnol, 2010; 87(6):2257-66.

Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med, 2011; 364:2392-240.

Solis G, de Los Reyes-Gavilan CG, Fernandez N, Margolles A, Gueimonde M. Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut. Anaerobe, 2010; 16:307-310.

Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F, Malagelada JR. Increased mucosal tumor necrosis factor alpha production in Corhns disease can be down regulated ex-vivo by probiotic bacteria. Gut, 2002; 51:659-664.

Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev, 2003; 8:223-246.

Hoarau C, Lagaraine C, Martin I, Velge-Roussel F, Lecranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor pathway. J Allergy Clin Immunol, 2006; 117:696-702.

Konstantinov SR, Smidt H, De Vos WM, Bruijns SC, Singh SK, Valence F. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci, 2008; 105:19474-19479.

Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol, 2008; 295:G1025–G1034.

Article Metrics

479 Absract views 18 PDF Downloads 497 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required